Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 119

1.

The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmatics.

Solèr M, Matz J, Townley R, Buhl R, O'Brien J, Fox H, Thirlwell J, Gupta N, Della Cioppa G.

Eur Respir J. 2001 Aug;18(2):254-61. Erratum in: Eur Respir J 2001 Oct;18(4):739-40.

2.

Omalizumab for asthma in adults and children.

Normansell R, Walker S, Milan SJ, Walters EH, Nair P.

Cochrane Database Syst Rev. 2014 Jan 13;(1):CD003559. doi: 10.1002/14651858.CD003559.pub4. Review.

PMID:
24414989
3.

Spotlight on omalizumab in allergic asthma.

Bang LM, Plosker GL.

BioDrugs. 2004;18(6):415-8. Review.

PMID:
15571425
4.

Omalizumab: a review of its use in the management of allergic asthma.

Bang LM, Plosker GL.

Treat Respir Med. 2004;3(3):183-99. Review.

PMID:
15219177
5.

Anti-IgE for chronic asthma in adults and children.

Walker S, Monteil M, Phelan K, Lasserson TJ, Walters EH.

Cochrane Database Syst Rev. 2004;(3):CD003559. Review. Update in: Cochrane Database Syst Rev. 2006;(2):CD003559.

PMID:
15266491
6.

Anti-IgE for chronic asthma in adults and children.

Walker S, Monteil M, Phelan K, Lasserson TJ, Walters EH.

Cochrane Database Syst Rev. 2006 Apr 19;(2):CD003559. Review. Update in: Cochrane Database Syst Rev. 2014;1:CD003559.

PMID:
16625585
7.

A recombinant humanized anti-IgE monoclonal antibody (omalizumab) in the therapy of moderate-to-severe allergic asthma.

D'Amato G, Piccolo A, Salzillo A, Noschese P, D'Amato M, Liccardi G.

Recent Pat Inflamm Allergy Drug Discov. 2007 Nov;1(3):225-31. Review.

PMID:
19075985
8.

[Anti IgE antibodies for the treatment of difficult asthma].

Humbert M, Tonnel AB.

Rev Mal Respir. 2005 Dec;22(6 Pt 1):983-90. Review. French.

PMID:
16222222
9.

Anti-IgE for chronic asthma.

Walker S, Monteil M, Phelan K, Lasserson TJ, Walters EH.

Cochrane Database Syst Rev. 2003;(3):CD003559. Review. Update in: Cochrane Database Syst Rev. 2004;(3):CD003559.

PMID:
12917972
10.

Anti-IgE therapy with omalizumab in asthma and allergic rhinitis.

Dodig S, Richter D, Cepelak I, Benko B.

Acta Pharm. 2005 Jun;55(2):123-38. Review.

PMID:
16179127
11.

Omalizumab in the treatment of severe asthma: efficacy and current problems.

Pelaia G, Renda T, Romeo P, Busceti MT, Maselli R.

Ther Adv Respir Dis. 2008 Dec;2(6):409-21. doi: 10.1177/1753465808100431. Review.

PMID:
19124386
12.

Anti-IgE antibodies for the treatment of asthma.

Buhl R.

Curr Opin Pulm Med. 2005 Jan;11(1):27-34. Review.

PMID:
15591885
13.

Does anti-IgE therapy help in asthma? Efficacy and controversies.

Avila PC.

Annu Rev Med. 2007;58:185-203. Review.

PMID:
17059361
14.

Omalizumab: a review of its use in the treatment of allergic asthma.

Plosker GL, Keam SJ.

BioDrugs. 2008;22(3):189-204. Review.

PMID:
18481901
15.

Omalizumab: a recombinant humanized anti-IgE antibody for allergic asthma.

Ruffin CG, Busch BE.

Am J Health Syst Pharm. 2004 Jul 15;61(14):1449-59. Review.

PMID:
15332692
16.

Anti-immunoglobulin E therapy with omalizumab for asthma.

Hendeles L, Sorkness CA.

Ann Pharmacother. 2007 Sep;41(9):1397-410. Epub 2007 Aug 14. Review.

PMID:
17698897
17.

Anti-immunoglobulin E treatment with omalizumab in allergic diseases: an update on anti-inflammatory activity and clinical efficacy.

Holgate ST, Djukanović R, Casale T, Bousquet J.

Clin Exp Allergy. 2005 Apr;35(4):408-16. Review.

PMID:
15836747
18.

Management of asthma with anti-immunoglobulin E: a review of clinical trials of omalizumab.

Nowak D.

Respir Med. 2006 Nov;100(11):1907-17. Epub 2006 Sep 1. Review.

19.
20.

The role of omalizumab in the treatment of severe allergic asthma.

Chapman KR, Cartier A, Hébert J, McIvor RA, Schellenberg RR.

Can Respir J. 2006 Jul-Aug;13 Suppl B:1B-9B. Review.

Supplemental Content

Support Center